ClinicalTrials.Veeva

Menu

Exercise and Nutritional Intervention for Deconditioned Older Adults

US Department of Veterans Affairs (VA) logo

US Department of Veterans Affairs (VA)

Status

Withdrawn

Conditions

Muscle Weakness

Treatments

Dietary Supplement: Protein and HMB (see below) supplement
Other: Resistance exercise

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT01115530
E7142-R

Details and patient eligibility

About

In this study we will evaluate whether the addition of a formal lower extremity resistance exercise training program and/or a nutritional supplement will improve the functional recovery of older adult veterans participating in a geriatric rehabilitation program for deconditioning. Specifically, subjects admitted to a geriatric inpatient rehabilitation program with a diagnosis of deconditioning will be randomly assigned to one of four groups; 1) Control/standard rehabilitation program, 2) Standard rehabilitation plus resistance exercise twice per week, 3) Standard rehabilitation plus a daily nutritional supplement, 4) Standard rehabilitation plus the resistance exercise and the nutritional supplement. Subjects will participate in each program for 12 weeks. At the beginning and end of the study we will measure lower extremity strength, walking speed, and overall function (using the standardized Functional Independence Measure), and compare the changes in each group.

Sex

Male

Ages

65 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Veteran admitted to GEM rehabilitation unit
  • Primary problem: Deconditioning/Generalized Weakness
  • Age 65-90
  • Self reported ability to report to the CAVHS GRECC twice per week after discharge from the GEM unit.
  • Living in the community prior to recent acute care hospitalization
  • Decision making capacity to be able to consent to the study as documented in the GEM attending or GEM APN's admission note

Exclusion criteria

  • Conditions that are exclusionary criteria for GEM admission including the following: direct transfer from any ICU, end-stage chronic medical/surgical disorder with no rehabilitation potential, terminal diagnosis /hospice/respite care, hemodialysis, active radiation therapy. Also, Type I diabetes mellitus
  • Any other condition considered exclusionary by the PI / study physician.

Prior to group assignment, subjects will be evaluated for contraindications to exercise training per the American College of Sports Medicine (ACSM)guidelines including the following:

  • Myocardial infarction documented in the past 3 months
  • Unstable angina (at rest in past 3 months, or increased angina pattern in past month)
  • Uncorrected left main coronary obstruction > 50%;
  • Congestive heart failure exacerbation in past 3 months (symptoms at rest or worsening symptoms requiring change in baseline diuretic dose)
  • Severe valvular heart disease (aortic or mitral stenosis with valve area < 1 cm2 , mitral or aortic insufficiency with any degree of LV dysfunction, pulmonary hypertension [PASP > 50 mmHg], or LV enlargement [LVESD 40 mm, or LVEDD > 55 mm])
  • Active pericarditis / myocarditis
  • Malignant or unstable arrhythmias, third degree AV block without pacemaker
  • Elevated resting blood pressure (systolic > 200 mmHg, diastolic > 110 mmHg)
  • Known large (> 4 cm) aortic aneurysm
  • Known cerebral aneurysm or intracranial bleed in past 1 year
  • Terminal cancer
  • Acute retinal hemorrhage or ophthalmologic surgery within 3 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 4 patient groups

1
No Intervention group
Description:
Control inpatient GEM rehabilitation and continue twice weekly low level walking/stretching to control for time/interaction with intervention/exercise groups
2
Experimental group
Description:
Resistance exercise (2x/week)
Treatment:
Other: Resistance exercise
3
Experimental group
Description:
Nutritional (amino acid metabolite) supplement twice daily
Treatment:
Dietary Supplement: Protein and HMB (see below) supplement
4
Experimental group
Description:
Resistance exercise (2x/week) and nutritional (amino acid metabolite) supplement twice daily
Treatment:
Other: Resistance exercise
Dietary Supplement: Protein and HMB (see below) supplement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems